Blood

ISSN: 0006-4971

Journal Home

Journal Guideline

Blood Q1 Unclaimed

American Society of Hematology United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Blood, the official journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Acceptance of manuscripts is based on the originality and importance of the observations or investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field. All articles are expected to be concise, well organized and clearly written. It has an SJR impact factor of 5,515.

Blood focuses its scope in these topics and keywords: cell, cells, patients, leukemia, chronic, stem, t, blood, hematopoietic, human, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

3170 €

Inmediate OA

NPD

Embargoed OA

910 €

Non OA

Metrics

Blood

5,515

SJR Impact factor

465

H Index

853

Total Docs (Last Year)

2755

Total Docs (3 years)

26498

Total Refs

22558

Total Cites (3 years)

2041

Citable Docs (3 years)

7,41

Cites/Doc (2 years)

31,06

Ref/Doc

Aims and Scope


cell, cells, patients, leukemia, chronic, stem, t, blood, hematopoietic, human, risk, lymphoma, disease, bcell, murine, myeloma, myeloid, multiple, regulation, signaling, study, model, transplantation,



Best articles by citations

HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy

View more

Busulfan bioavailability

View more

Epstein-Barr virus associated B-cell lymphoproliferation in an infant treated for acute lymphoblastic leukemia [letter]

View more

JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma

View more

Expression and function of the endothelial protein C receptor in human neutrophils

View more

Evidence-based focused review of the role of radiation therapy in the treatment of early-stage Hodgkin lymphoma

View more

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients

View more

Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome

View more

Eosinophils are a major intravascular location for tissue factor storage and exposure

View more

Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma

View more

Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors

View more

IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis

View more
SHOW MORE ARTICLES

Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes

View more

Dermal and pulmonary inflammatory disease in E-selectin and P-selectin double-null mice is reduced in triple-selectin-null mice

View more

Cell-surface trafficking and release of flt3 ligand from T lymphocytes is induced by common cytokine receptor gamma-chain signaling and inhibited by cyclosporin A

View more

Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand

View more

Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity

View more

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma

View more

Evaluation of the Regimen Brentuximab Vedotin Plus ESHAP (BRESHAP) in Refractory or Relapsed Hodgkin Lymphoma Patients: Preliminary Results of a Phase I-II Trial from the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

View more

Clonotypic B cells in classic Hodgkin lymphoma

View more

Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event

View more

Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma

View more

A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies

View more

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

View more

Comments

No comments ... Be the first to comment!

FAQS